Caroline Helwick[email protected]MRIBreast MRI pinpoints residual disease after chemotherapyBreast MRI accurately reflects the pathologic extent of residual disease following neoadjuvant chemotherapy, and tumor size and contrast kinetics measured by MRI may be useful early predictors of treatment response, according to a study presented at the San Antonio Breast Cancer Symposium.December 18, 2008Page 1 of 1Top StoriesDigital X-RayBone-RADS improves accuracy for junior, attending physicansACR's Bone-RADS led to improved diagnostic accuracy for junior and attending physicians, but lower accuracy for senior physicians.MRIMRI, CT, ultrasound biomarkers help identify Crohn disease stricturesWomens ImagingLow breast cancer screening prevalence tied to socioeconomic factorsMolecular ImagingPET/CT reveals ‘chemo brain’ regions in leukemia patientsAIStanford AIDE lab proposes radiology AI safety monitoring model